NCT00569764UnknownNot Applicable
The Effects of Metabolic Parameters of Aripiprazole in Patients With Schizophrenia
Seoul National Hospital1 site in 1 country100 target enrollmentStarted: December 2007Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- weight lipid profile : HDL, LDL, total-cholesterol, triglyceride fasting blood glucose
Study Overview
Brief Summary
To measure the long-term changes in weight and plasma lipids after switching antipsychotic treatment to aripiprazole
Detailed Description
To measure the long-term changes in weight, plasma lipids and fasting blood glucose after switching antipsychotic treatment to aripiprazole, 1 year, open label studies in out and in-patients with schizophrenia.
The measurement of weight and lipid profile and fasting blood glucose will be measured at baseline and every 3 months for 1 year.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •DSM-IV diagnosis with schizophrenia
- •who signed an informed consent
Exclusion Criteria
- •comorbid with substance abuse or substance dependence
- •pregnancy or lactation
Outcomes
Primary Outcomes
weight lipid profile : HDL, LDL, total-cholesterol, triglyceride fasting blood glucose
Time Frame: 1 year
Secondary Outcomes
- prolactin ECG(1 year)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 4
Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar DisordersBipolar DisordersMetabolic ComplicationNCT00845988Seoul National University Hospital28
Completed
Phase 1
Diabetes in Neuropsychiatric DisordersSchizophreniaNCT00446992National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)30
Withdrawn
Phase 2
Metabolic Effects of Antipsychotic Substitution in ChildrenDiabetesNCT00910780Washington University School of Medicine
Completed
Phase 4
Energy Homeostasis Under Treatment With Atypical AntipsychoticsSchizophreniaNCT00148564Charite University, Berlin, Germany40
Completed
Not Applicable
Long-term Antipsychotic Pediatric Safety TrialWeight, BodyNCT03522168Duke University509